Breast Cancer Previvor Shares Her Health Journey with Monmouth Medical Center High Risk Breast Cancer Program | Newswise
Published . Updated .
Breast Cancer Previvor Shares Her Health Journey with Monmouth Medical Center High Risk Breast Cancer Program | Newswise Newswise
Directly affected
- No company is named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
A fund of health-care companies
- XBI SPDR S&P Biotech
A fund of biotechnology companies
- UNH UnitedHealth
A large health insurer
- JNJ Johnson & Johnson
A large health-care company
- LLY Eli Lilly
A large drug maker
- PFE Pfizer
A large drug maker
- NAMS NEW AMSTERDAM PHARMA CO ORDINARY SHARES
GA selected NAMS as a RELATED security because its canonical security name directly matches this event's themes: pharma, shares. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ACHC ACADIA HEALTHCARE COMPANY INC
GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ASND ASCENDIS PHARMA A/S
GA selected ASND as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ATYR ATYR PHARMA INC COM NEW
GA selected ATYR as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
Breast Cancer Previvor Shares Her Health Journey with Monmouth Medical Center High Risk Breast Cancer Program | Newswise Newswise
Source: Newswise
How far NewAmsterdam Pharma Co N.V (NAMS) has moved since 13 Oct 2026
Since the first closing price after “Breast Cancer Previvor Shares Her Health Journey with Monmouth Medical Center High Risk Breast Cancer Program | Newswise,” NewAmsterdam Pharma Co N.V (NAMS) is +2.37%. The S&P 500 fund (SPY) is -0.40% over the same days, a +2.77% difference versus the market.
| Company | When | Move | Status |
|---|---|---|---|
| Acadia Healthcare (ACHC) | that day | +0.50% | final price |
| Acadia Healthcare (ACHC) | the next day | +5.29% | final price |
| Acadia Healthcare (ACHC) | two days later | +3.19% | final price |
| Acadia Healthcare (ACHC) | three days later | -0.33% | final price |
| Acadia Healthcare (ACHC) | three days earlier | -5.32% | final price |
| Acadia Healthcare (ACHC) | five days earlier | -3.46% | final price |
| Ascendis Pharma A/S (ASND) | that day | -1.62% | final price |
| Ascendis Pharma A/S (ASND) | the next day | +0.04% | final price |
| Ascendis Pharma A/S (ASND) | two days later | -0.14% | final price |
| Ascendis Pharma A/S (ASND) | three days later | -0.76% | final price |
| Ascendis Pharma A/S (ASND) | three days earlier | -1.88% | final price |
| Ascendis Pharma A/S (ASND) | five days earlier | -0.35% | final price |
| aTYR PHARMA (ATYR) | that day | -7.79% | final price |
| aTYR PHARMA (ATYR) | the next day | -16.23% | final price |
| aTYR PHARMA (ATYR) | two days later | -14.52% | final price |
| aTYR PHARMA (ATYR) | three days later | -18.17% | final price |
| aTYR PHARMA (ATYR) | three days earlier | +18.40% | final price |
| aTYR PHARMA (ATYR) | five days earlier | +30.15% | final price |
| JNJ | that day | -5.73% | final price |
| JNJ | the next day | -3.72% | final price |
| JNJ | two days later | -3.96% | final price |
| JNJ | three days later | -3.10% | final price |
| JNJ | three days earlier | -2.75% | final price |
| JNJ | five days earlier | -3.39% | final price |
| LLY | that day | -1.36% | final price |
| LLY | the next day | +2.21% | final price |
| LLY | two days later | +5.83% | final price |
| LLY | three days later | +6.29% | final price |
| LLY | three days earlier | -1.10% | final price |
| LLY | five days earlier | -2.12% | final price |
Disclosure records for NewAmsterdam Pharma Co N.V (NAMS) within two months of 13 Oct 2026
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around NewAmsterdam Pharma Co N.V (NAMS)
Companies mentioned with this story
- NAMS NewAmsterdam Pharma Co N.V
For “Breast Cancer Previvor Shares Her Health Journey with Monmouth Medical Center High Risk Breast Cancer Program | Newswise,” NewAmsterdam Pharma Co N.V (NAMS) is linked, with no stored direction, medium confidence. Reason on file: GA selected NAMS as a RELATED security because its canonical security name directly matches this event's themes: pharma, shares. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ACHC Acadia Healthcare
Acadia Healthcare (ACHC) is linked, with no stored direction, medium confidence in the 13 Oct 2026 story “Breast Cancer Previvor Shares Her Health Journey with Monmouth Medical Center High Risk Breast Cancer Program | Newswise.” Reason on file: GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ASND Ascendis Pharma A/S
For “Breast Cancer Previvor Shares Her Health Journey with Monmouth Medical Center High Risk Breast Cancer Program | Newswise,” Ascendis Pharma A/S (ASND) is linked, with no stored direction, medium confidence. Reason on file: GA selected ASND as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ATYR aTYR PHARMA
In “Breast Cancer Previvor Shares Her Health Journey with Monmouth Medical Center High Risk Breast Cancer Program | Newswise,” aTYR PHARMA (ATYR) is linked, with no stored direction, medium confidence. Reason on file: GA selected ATYR as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- BBIO BridgeBio Pharma
BridgeBio Pharma (BBIO) is linked, with no stored direction, medium confidence in the 13 Oct 2026 story “Breast Cancer Previvor Shares Her Health Journey with Monmouth Medical Center High Risk Breast Cancer Program | Newswise.” Reason on file: GA selected BBIO as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- CRDF Cardiff Oncology
Cardiff Oncology (CRDF) is linked, with no stored direction, medium confidence in the 13 Oct 2026 story “Breast Cancer Previvor Shares Her Health Journey with Monmouth Medical Center High Risk Breast Cancer Program | Newswise.” Reason on file: GA selected CRDF as a RELATED security because its canonical security name directly matches this event's themes: oncology. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
NewAmsterdam Pharma Co N.V (NAMS)
The 13 Oct 2026 story “Breast Cancer Previvor Shares Her Health Journey with Monmouth Medical Center High Risk Breast Cancer Program | Newswise” names NewAmsterdam Pharma Co N.V (NAMS) because of this story.
NewAmsterdam Pharma Co N.V (NAMS) is on the page because GA selected NAMS as a RELATED security because its canonical security name directly matches this event's themes: pharma, shares. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
A second company, Acadia Healthcare (ACHC), is listed for a different reason: GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Dates and price levels for NewAmsterdam Pharma Co N.V (NAMS)
ACHC traded between 26.75 and 32.03 across 20 sessions. The latest close on file is 30.20. ASND traded between 219.69 and 240.84 across 20 sessions. The latest close on file is 229.99. NAMS traded between 19.58 and 25.10 across 20 sessions. The latest close on file is 20.49.
A simple score for NewAmsterdam Pharma Co N.V (NAMS)
54 out of 100
“Breast Cancer Previvor Shares Her Health Journey with Monmouth Medical Center High Risk Breast Cancer Program | Newswise” scores 54 out of 100. The score uses 2 sources, and 6 linked companies.